Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
8.39
-0.61 (-6.73%)
At close: May 12, 2025, 4:00 PM
8.40
+0.02 (0.18%)
After-hours: May 12, 2025, 6:52 PM EDT
Nuvectis Pharma Market Cap
Nuvectis Pharma has a market cap or net worth of $198.18 million as of May 12, 2025. Its market cap has increased by 66.21% in one year.
Market Cap
198.18M
Enterprise Value
168.31M
1-Year Change
66.21%
Ranking
Category
Stock Price
$8.39
Market Cap Chart
Since the IPO on February 4, 2022, Nuvectis Pharma's market cap has increased from $58.01M to $198.18M, an increase of 241.65%. That is a compound annual growth rate of 45.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 212.47M | 103.27% |
| Dec 31, 2024 | 104.53M | -27.67% |
| Dec 29, 2023 | 144.50M | 31.58% |
| Dec 30, 2022 | 109.82M | 89.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |